# AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

> **NCT03691844** · PHASE2,PHASE3 · COMPLETED · sponsor: **Amzell** · enrollment: 444 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** AMZ001
- **DRUG:** Placebo
- **DRUG:** Comparator

## Key facts

- **NCT ID:** NCT03691844
- **Lead sponsor:** Amzell
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-04
- **Primary completion:** 2019-07-09
- **Final completion:** 2019-07-09
- **Target enrollment:** 444 (ACTUAL)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03691844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03691844, "AMZ001 for the Treatment of Knee Osteoarthritis Symptoms". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03691844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*